<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:access="http://www.bloglines.com/about/specs/fac-1.0">
<access:restriction relationship="allow" />
<channel>
<title>pharmlib</title>
<link>http://pharmlib.pbwiki.com/</link>
<description>RecentChanges for pharmlib</description>
<image>
 <url>http://pharmlib.pbwiki.com/feedlogo.gif</url>
 <title>PBwiki</title>
 <link>http://pbwiki.com/</link>
</image>
<generator>PBwiki 1.3.8</generator>
<webMaster>support@pbwiki.com</webMaster>
 <item>
  <title>Pharmacy Subject Guides</title>
  <link>http://pharmlib.pbwiki.com/Pharmacy+Subject+Guides</link>
  <author>email.hidden@example.com (Gerri Wanserski)</author>
  <description><![CDATA[<h3>Gerri Wanserski edited <a href="http://pharmlib.pbwiki.com/Pharmacy+Subject+Guides">Pharmacy Subject Guides</a></h3>
General Pharmacy<br /><span style="color:red;background-color:#fcc;">Drug</span><span style="color:red;background-color:#fcc;"> Information:</span><span style="color:red;background-color:#fcc;"> Online</span><span style="color:red;background-color:#fcc;"> Resources(UNC-Chapel</span><span style="font-weight:bold;color:green;background-color:#cfc;">DrugInformation:OnlineResources</span><span style="font-weight:bold;color:green;background-color:#cfc;"> (UNC-Chapel</span> Hill)<span style="color:red;background-color:#fcc;"><br />Pharmacy</span><span style="color:red;background-color:#fcc;"> Internet</span><span style="color:red;background-color:#fcc;"> Resources(UMB)</span><span style="color:red;background-color:#fcc;"><br />Pharmacy</span><span style="color:red;background-color:#fcc;"> Resources(U.</span><span style="font-weight:bold;color:green;background-color:#cfc;"><br />PharmacyInternetResources</span><span style="font-weight:bold;color:green;background-color:#cfc;"> (UMB)</span><span style="font-weight:bold;color:green;background-color:#cfc;"><br />PharmacyResources</span><span style="font-weight:bold;color:green;background-color:#cfc;"> (U.</span> Wisc)<span style="color:red;background-color:#fcc;"><br />Pharmacy</span><span style="color:red;background-color:#fcc;"> Resources</span><span style="color:red;background-color:#fcc;"> Wiki(U.Buffalo)</span><span style="color:red;background-color:#fcc;"><br />Subject</span><span style="color:red;background-color:#fcc;"> Resources</span><span style="color:red;background-color:#fcc;"> for</span><span style="color:red;background-color:#fcc;"> Pharmaceutical</span><span style="color:red;background-color:#fcc;"> Sciences/Pharmacy(UBC)</span><span style="color:red;background-color:#fcc;"><br />Pharmacy</span><span style="color:red;background-color:#fcc;"> &amp;</span><span style="color:red;background-color:#fcc;"> Pharmacology</span><span style="color:red;background-color:#fcc;"> Resources</span><span style="font-weight:bold;color:green;background-color:#cfc;"><br />PharmacyResourcesWiki</span><span style="font-weight:bold;color:green;background-color:#cfc;"> (U.</span><span style="font-weight:bold;color:green;background-color:#cfc;"> Buffalo)</span><span style="font-weight:bold;color:green;background-color:#cfc;"><br />SubjectResourcesforPharmaceuticalSciences/Pharmacy</span><span style="font-weight:bold;color:green;background-color:#cfc;"> (UBC)</span><span style="font-weight:bold;color:green;background-color:#cfc;"><br />Pharmacy&amp;PharmacologyResources</span> (UTHSC-Memphis)<br />Specific Areas in Pharmacy<br /><span style="color:red;background-color:#fcc;">Clinical</span><span style="color:red;background-color:#fcc;"> Pharmacology(UNC-Chapel</span><span style="font-weight:bold;color:green;background-color:#cfc;">ClinicalPharmacology</span><span style="font-weight:bold;color:green;background-color:#cfc;"> (</span>]]></description>
  <pubDate>Fri, 04 Jan 2008 23:35:20 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Pharmacy Librarians</title>
  <link>http://pharmlib.pbwiki.com/Pharmacy+Librarians</link>
  <author>email.hidden@example.com (Lin)</author>
  <description><![CDATA[<h3>Lin edited <a href="http://pharmlib.pbwiki.com/Pharmacy+Librarians">Pharmacy Librarians</a></h3>
K.T. Vaughan- University of North Carolina at Chapel Hill (wiki editor)<br />Gerri Wanserski- University of Wisconsin at Madison<br /><span style="font-weight:bold;color:green;background-color:#cfc;">Lin Wu - University of Tennessee at Memphis (wiki editor)</span><br />.<br />.<br />]]></description>
  <pubDate>Wed, 14 Nov 2007 17:56:32 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>FrontPage</title>
  <link>http://pharmlib.pbwiki.com/FrontPage</link>
  <author>email.hidden@example.com (Lin)</author>
  <description><![CDATA[<h3>Lin edited <a href="http://pharmlib.pbwiki.com/FrontPage">FrontPage</a>]]></description>
  <pubDate>Wed, 14 Nov 2007 17:37:05 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Interesting Articles</title>
  <link>http://pharmlib.pbwiki.com/Interesting+Articles</link>
  <author>email.hidden@example.com (Lin)</author>
  <description><![CDATA[<h3>Lin edited <a href="http://pharmlib.pbwiki.com/Interesting+Articles">Interesting Articles</a></h3>
 Jan;92(1):66-71.<span style="color:red;background-color:#fcc;"><br />Full</span><span style="font-weight:bold;color:green;background-color:#cfc;"> Full</span> Text<br />]]></description>
  <pubDate>Wed, 14 Nov 2007 17:27:43 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Interesting Articles</title>
  <link>http://pharmlib.pbwiki.com/Interesting+Articles</link>
  <author>email.hidden@example.com (Lin)</author>
  <description><![CDATA[<h3>Lin edited <a href="http://pharmlib.pbwiki.com/Interesting+Articles">Interesting Articles</a></h3>
Kupferberg<span style="color:red;background-color:#fcc;"> N,&amp;amp;</span><span style="font-weight:bold;color:green;background-color:#cfc;"> N,&amp;</span> Jones Hartel L. Evaluation of five full-text drug databases by pharmacy students, faculty, and librarians: do the groups agree? J Med Libr Assoc. 2004 Jan;92(1):66-71.<br />Full Text<br />]]></description>
  <pubDate>Wed, 14 Nov 2007 17:27:24 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Interesting Articles</title>
  <link>http://pharmlib.pbwiki.com/Interesting+Articles</link>
  <author>email.hidden@example.com (Lin)</author>
  <description><![CDATA[<h3>Lin edited <a href="http://pharmlib.pbwiki.com/Interesting+Articles">Interesting Articles</a></h3>
Kupferberg<span style="color:red;background-color:#fcc;"> N,</span><span style="font-weight:bold;color:green;background-color:#cfc;"> N,&amp;amp;</span> Jones Hartel L. Evaluation of five full-text drug databases by pharmacy<span style="color:red;background-color:#fcc;"><br />students,</span><span style="font-weight:bold;color:green;background-color:#cfc;"> students,</span> faculty, and librarians: do the groups agree? J Med Libr Assoc. 2004 Jan;92(1):66-71.<br />Full Text<br />]]></description>
  <pubDate>Wed, 14 Nov 2007 17:27:05 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Interesting Articles</title>
  <link>http://pharmlib.pbwiki.com/Interesting+Articles</link>
  <author>email.hidden@example.com (Lin)</author>
  <description><![CDATA[<h3>Lin edited <a href="http://pharmlib.pbwiki.com/Interesting+Articles">Interesting Articles</a></h3>
 pharmacy<span style="color:red;background-color:#fcc;"> students,</span><span style="font-weight:bold;color:green;background-color:#cfc;"><br />students,</span> faculty, and librarians: do the groups agree? J Med Libr Assoc. 2004<span style="color:red;background-color:#fcc;"> Jan;92(1):66-71.PMID:</span><span style="color:red;background-color:#fcc;"> 14762464</span><span style="color:red;background-color:#fcc;"> [PubMed</span><span style="color:red;background-color:#fcc;"> -</span><span style="color:red;background-color:#fcc;"> indexed</span><span style="color:red;background-color:#fcc;"> for</span><span style="color:red;background-color:#fcc;"> MEDLINE]</span><span style="font-weight:bold;color:green;background-color:#cfc;"> Jan;92(1):66-71.</span><span style="font-weight:bold;color:green;background-color:#cfc;"><br />Full</span><span style="font-weight:bold;color:green;background-color:#cfc;"> Text</span><br />]]></description>
  <pubDate>Wed, 14 Nov 2007 17:26:22 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Interesting Articles</title>
  <link>http://pharmlib.pbwiki.com/Interesting+Articles</link>
  <author>email.hidden@example.com (Lin)</author>
  <description><![CDATA[<h3>Lin added <a href="http://pharmlib.pbwiki.com/Interesting+Articles">Interesting Articles</a></h3>
<p>&nbsp;</p><br />
<pre>Kupferberg N, Jones Hartel L. <a href="/Evaluation of five full-text drug databases by pharmacy students, faculty, and" class="WikiLink">Evaluation of five full-text drug databases by pharmacy students, faculty, and librarians: do the groups agree?</a> J Med Libr Assoc. 2004 Jan;92(1):66-71.<br />PMID: 14762464 [PubMed - indexed for MEDLINE]</pre><br />
]]></description>
  <pubDate>Wed, 14 Nov 2007 17:23:05 +0000</pubDate>
  <category>add</category>
 </item>
 <item>
  <title>FrontPage</title>
  <link>http://pharmlib.pbwiki.com/FrontPage</link>
  <author>email.hidden@example.com (Lin)</author>
  <description><![CDATA[<h3>Lin edited <a href="http://pharmlib.pbwiki.com/FrontPage">FrontPage</a></h3>
Special Libraries Association Pharmaceutical &amp; Health Techologies Division<br />Upcoming conferences<br /><span style="font-weight:bold;color:green;background-color:#cfc;">AACP 2008<br />MLA 2008</span><br />Continuing education opportunities<br />Job discovery<br />]]></description>
  <pubDate>Wed, 14 Nov 2007 17:06:47 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Search questions</title>
  <link>http://pharmlib.pbwiki.com/Search+questions</link>
  <author>email.hidden@example.com (KT)</author>
  <description><![CDATA[<h3>KT edited <a href="http://pharmlib.pbwiki.com/Search+questions">Search questions</a></h3>
13) Are there dosage adjustments required in obese patients receiving enoxaparin for thromboprophylaxis or treatment of DVT? (from Marlene Dorgan)<br />14) With all of the concern about Avandia lately, you’ve decided to see what information is known about another type 2 diabetes drug, Actos (pioglitazone). In particular, you want to know if there is a connection known between heart health and this drug. (from KT Vaughan)<br /> Syndrome?<span style="color:red;background-color:#fcc;"> Find</span><span style="font-weight:bold;color:green;background-color:#cfc;">  Find</span> any English case reports dealing with human adolescents. (from Jonathan Koffel for PubMed)<br />16) A patient is taking lovastatin. Could this have caused her to develop rhabdomyolysis?<span style="color:red;background-color:#fcc;"> Find</span><span style="font-weight:bold;color:green;background-color:#cfc;">  Find</span> any review articles written in the last 3 years in English about a human population. (from Jonathan Koffel for PubMed)<br />17) A patient is taking aspirin and clopidogrel.<span style="color:red;background-color:#fcc;"> Could</span><span style="font-weight:bold;color:green;background-color:#cfc;">  Could</span> this have caused her to develop a duodenal ulcer?<span style="color:red;background-color:#fcc;"> Find</span><span style="font-weight:bold;color:green;background-color:#cfc;">  Find</span> any review articles written in English about t]]></description>
  <pubDate>Fri, 28 Sep 2007 10:45:02 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Search questions</title>
  <link>http://pharmlib.pbwiki.com/Search+questions</link>
  <author>email.hidden@example.com (Jonathan Koffel)</author>
  <description><![CDATA[<h3>Jonathan Koffel edited <a href="http://pharmlib.pbwiki.com/Search+questions">Search questions</a></h3>
26) A patient who is receiving interferon alfa-2b presents with a new prescription for gemfibrozil. Should the patient be monitored for a possible drug interaction? (from Jonathan Koffel for PubMed)<br />27) A nurse at an assisted living facility would like to know if olanzapine can cause delirium in the elderly. (posted by Jonathan Koffel, written by Vern Duba for IPA)<br /> disorder?<span style="color:red;background-color:#fcc;"><br />(posted</span><span style="font-weight:bold;color:green;background-color:#cfc;"> (posted</span> by Jonathan Koffel, written by Vern Duba for IPA)<br />29) For your pharmaceutical socioeconomics class you have to write a paper that discusses whether or not generic substitution of generic drugs would affect adherence. (posted by Jonathan Koffel, written by Vern Duba for IPA)<br />30) A patient with a history of symptomatic thromboembolism is about to undergo orthopedic surgery. The doctor would like to know if low-dose warfarin can be used for prevention of symptomatic thromboembolism after orthopedic surgery. (posted by Jonathan Koffel, written by Vern Duba for IPA)<br />]]></description>
  <pubDate>Fri, 28 Sep 2007 10:19:57 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Search questions</title>
  <link>http://pharmlib.pbwiki.com/Search+questions</link>
  <author>email.hidden@example.com (Jonathan Koffel)</author>
  <description><![CDATA[<h3>Jonathan Koffel edited <a href="http://pharmlib.pbwiki.com/Search+questions">Search questions</a></h3>
26) A patient who is receiving interferon alfa-2b presents with a new prescription for gemfibrozil. Should the patient be monitored for a possible drug interaction? (from Jonathan Koffel for PubMed)<br />27) A nurse at an assisted living facility would like to know if olanzapine can cause delirium in the elderly. (posted by Jonathan Koffel, written by Vern Duba for IPA)<br /> disorder?<span style="color:red;background-color:#fcc;"> (posted</span><span style="font-weight:bold;color:green;background-color:#cfc;"><br />(posted</span> by Jonathan Koffel, written by Vern Duba for IPA)<br />29) For your pharmaceutical socioeconomics class you have to write a paper that discusses whether or not generic substitution of generic drugs would affect adherence. (posted by Jonathan Koffel, written by Vern Duba for IPA)<br />30) A patient with a history of symptomatic thromboembolism is about to undergo orthopedic surgery. The doctor would like to know if low-dose warfarin can be used for prevention of symptomatic thromboembolism after orthopedic surgery. (posted by Jonathan Koffel, written by Vern Duba for IPA)<br />]]></description>
  <pubDate>Fri, 28 Sep 2007 10:19:31 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Search questions</title>
  <link>http://pharmlib.pbwiki.com/Search+questions</link>
  <author>email.hidden@example.com (Jonathan Koffel)</author>
  <description><![CDATA[<h3>Jonathan Koffel edited <a href="http://pharmlib.pbwiki.com/Search+questions">Search questions</a></h3>
13) Are there dosage adjustments required in obese patients receiving enoxaparin for thromboprophylaxis or treatment of DVT? (from Marlene Dorgan)<br />14) With all of the concern about Avandia lately, you’ve decided to see what information is known about another type 2 diabetes drug, Actos (pioglitazone). In particular, you want to know if there is a connection known between heart health and this drug. (from KT Vaughan)<br /><span style="font-weight:bold;color:green;background-color:#cfc;">15) A patient recently received the meningococcal vaccine. Could this have caused her to develop Guillain-Barre Syndrome? Find any English case reports dealing with human adolescents. (from Jonathan Koffel for PubMed)<br />16) A patient is taking lovastatin. Could this have caused her to develop rhabdomyolysis? Find any review articles written in the last 3 years in English about a human population. (from Jonathan Koffel for PubMed)<br />17) A patient is taking aspirin and clopidogrel. Could this have caused her to develop a duodenal ulcer? Find any review articles written in English abou</span>]]></description>
  <pubDate>Fri, 28 Sep 2007 10:18:35 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Search questions</title>
  <link>http://pharmlib.pbwiki.com/Search+questions</link>
  <author>email.hidden@example.com (KT)</author>
  <description><![CDATA[<h3>KT edited <a href="http://pharmlib.pbwiki.com/Search+questions">Search questions</a>]]></description>
  <pubDate>Fri, 28 Sep 2007 09:37:21 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Search questions</title>
  <link>http://pharmlib.pbwiki.com/Search+questions</link>
  <author>email.hidden@example.com (KT)</author>
  <description><![CDATA[<h3>KT edited <a href="http://pharmlib.pbwiki.com/Search+questions">Search questions</a></h3>
1) Use of modafinil by college students to remain functional while sleep deprived (from Brenda Green)<br />2) Locate articles that discuss pharmacies restricting access to over-the-counter pseudoephedrine in order to limit the illegal production of crystal meth. How many states have passed legislation on the matter? Are there any reported outcomes yet (i.e. less meth on the streets, fewer lab busts, etc.)? (from Stewart Brower)<br /> older<span style="color:red;background-color:#fcc;"> drug.You</span><span style="font-weight:bold;color:green;background-color:#cfc;"> drug.</span><span style="font-weight:bold;color:green;background-color:#cfc;"> You</span> decide to do some research into the relative efficacy of pseudoephedrine and phenylephrine. (from KT Vaughan)<br />3) Locate articles on the medical science behind the recent decision by Merck to pull Vioxx from the shelves. How long have we known about the possible risks of heart attack for users of Vioxx and other COX-2 inhibitors? (For Web of Science or Google Scholar searchers, what is the most-often cited article?) (from Stewart Brower)<br />4) Locate articles that discuss pharmacists refusing to distribute the “morning aft]]></description>
  <pubDate>Fri, 28 Sep 2007 09:36:59 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Search questions</title>
  <link>http://pharmlib.pbwiki.com/Search+questions</link>
  <author>email.hidden@example.com (KT)</author>
  <description><![CDATA[<h3>KT edited <a href="http://pharmlib.pbwiki.com/Search+questions">Search questions</a></h3>
1) Use of modafinil by college students to remain functional while sleep deprived (from Brenda Green)<br /> to<span style="color:red;background-color:#fcc;">  over-the-counter</span><span style="font-weight:bold;color:green;background-color:#cfc;"> over-the-counter</span> pseudoephedrine in order to limit the illegal<span style="color:red;background-color:#fcc;">  production</span><span style="font-weight:bold;color:green;background-color:#cfc;"> production</span> of crystal meth. How many states have passed legislation on<span style="color:red;background-color:#fcc;">  the</span><span style="font-weight:bold;color:green;background-color:#cfc;"> the</span> matter? Are there any reported outcomes yet (i.e. less meth on the<span style="color:red;background-color:#fcc;">  streets,</span><span style="font-weight:bold;color:green;background-color:#cfc;"> streets,</span> fewer lab busts, etc.)? (from Stewart Brower)<span style="font-weight:bold;color:green;background-color:#cfc;"><br />2a)</span><span style="font-weight:bold;color:green;background-color:#cfc;"> Clients</span><span style="font-weight:bold;color:green;background-color:#cfc;"> in</span><span style="font-weight:bold;color:green;background-color:#cfc;"> your</span><span style="font-weight:bold;color:green;background-color:#cfc;"> pharmacy</span><span style="font-weight:bold;color:green;background-color:#cfc;"> keep</span><span style="font-weight:bold;color:green;background-color:#cfc;"> asking</span><span style="font-weight:bold;color:green;background-color:#cfc;"> you</span><span style="font-weight:bold;color:green;background-color:#cfc;"> whether</span><span style="font-weight:bold;color:green;background-color:#cfc;"> the</span><span style="font-weight:bold;color:green;background-color:#cfc;"> new</span><span style="font-weight:bold;color:green;background-color:#cfc;"> Sudafed</span><span style="font-weight:bold;color:green;background-color:#cfc;"> PE</span><span style="font-weight:bold;color:green;background-color:#cfc;"> is</span><span style="font-weight:bold;color:green;background-color:#cfc;"> better</span><span style="font-weight:bold;color:green;background-color:#cfc;"> or</span><span style="font-weight:bold;color:green;background-color:#cfc;"> worse</span><span style="font-weight:bold;color:green;background-color:#cfc;"> than</span><span style="font-weight:bold;color:green;background-color:#cfc;"> classic</span><span style="font-weight:bold;color:green;background-color:#cfc;"> Sudafed</span><span style="font-weight:bold;color:green;background-color:#cfc;"> –</span><span style="font-weight:bold;color:green;background-color:#cfc;"> particularly</span><span style="font-weight:bold;color:green;background-color:#cfc;"> since</span><span style="font-weight:bold;color:green;background-color:#cfc;"> they</span><span style="font-weight:bold;color:green;background-color:#cfc;"> have</span><span style="font-weight:bold;color:green;background-color:#cfc;"> to</span><span style="font-weight:bold;color:green;background-color:#cfc;"> jump</span><span style="font-weight:bold;color:green;background-color:#cfc;"> through</span><span style="font-weight:bold;color:green;background-color:#cfc;"> a</span><span style="font-weight:bold;color:green;background-color:#cfc;"> lot</span><span style="font-weight:bold;color:green;background-color:#cfc;"> of</span><span style="font-weight:bold;color:green;background-color:#cfc;"> hoo</span>]]></description>
  <pubDate>Fri, 28 Sep 2007 09:36:18 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Pharmacy Librarians</title>
  <link>http://pharmlib.pbwiki.com/Pharmacy+Librarians</link>
  <author>email.hidden@example.com (Jonathan Koffel)</author>
  <description><![CDATA[<h3>Jonathan Koffel edited <a href="http://pharmlib.pbwiki.com/Pharmacy+Librarians">Pharmacy Librarians</a></h3>
Stewart Brower- University of Buffalo (wiki editor)<br />Rae Jesano- University of Florida<br /><span style="font-weight:bold;color:green;background-color:#cfc;">Jonathan Koffel - University of Iowa</span><br />Teresa Lee - University of British Columbia (wiki editor)<br />Julie Nanavati- University of Maryland at Baltimore (wiki editor)<br />]]></description>
  <pubDate>Mon, 24 Sep 2007 17:35:08 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Search questions</title>
  <link>http://pharmlib.pbwiki.com/Search+questions</link>
  <author>email.hidden@example.com (Teresa)</author>
  <description><![CDATA[<h3>Teresa edited <a href="http://pharmlib.pbwiki.com/Search+questions">Search questions</a>]]></description>
  <pubDate>Wed, 01 Aug 2007 17:56:19 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Search questions</title>
  <link>http://pharmlib.pbwiki.com/Search+questions</link>
  <author>email.hidden@example.com (Teresa)</author>
  <description><![CDATA[<h3>Teresa edited <a href="http://pharmlib.pbwiki.com/Search+questions">Search questions</a>]]></description>
  <pubDate>Wed, 01 Aug 2007 17:54:02 +0000</pubDate>
  <category>mod</category>
 </item>
 <item>
  <title>Search questions</title>
  <link>http://pharmlib.pbwiki.com/Search+questions</link>
  <author>email.hidden@example.com (Teresa)</author>
  <description><![CDATA[<h3>Teresa edited <a href="http://pharmlib.pbwiki.com/Search+questions">Search questions</a></h3>
8) Herbal medicine in treating diabetic foot. (from Lin Wu)<br />9) I would like to know any literature on drug interactions of oral  contraceptives and phenytoin. (from Lin Wu)<br /><span style="font-weight:bold;color:green;background-color:#cfc;">10) What evidence can you find for using acetylcysteine for contrast media-induced nephropathy? (from Marlene Dorgan)<br />11)	Is there any evidence/literature on inhaled furosemide used for the treatment of dyspnea? (from Marlene Dorgan)<br />12) What evidence/literature can be found for using dextromethorphan in the treatment of dyskinesias? (from Marlene Dorgan)<br />13) Are there dosage adjustments required in obese patients receiving enoxaparin for thromboprophylaxis or treatment of DVT? (from Marlene Dorgan)</span><br />]]></description>
  <pubDate>Wed, 01 Aug 2007 17:53:30 +0000</pubDate>
  <category>mod</category>
 </item>
</channel>
</rss>
